Eicos Sci Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EICOS SCI, and what generic and branded alternatives to EICOS SCI drugs are available?
EICOS SCI has one approved drug.
Summary for Eicos Sci
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Eicos Sci
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eicos Sci | AURLUMYN | iloprost | SOLUTION;INTRAVENOUS | 217933-001 | Feb 13, 2024 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Eicos Sci | AURLUMYN | iloprost | SOLUTION;INTRAVENOUS | 217933-001 | Feb 13, 2024 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
